Ibogaine research published in 2018

Page 2 of 2: studies 21 to 22 of 22, newest first. Back to the ibogaine overview

Studies

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.

Progress in Brain Research 2018 Joseph P Barsuglia, Martin Polanco, Robert Palmer et al. 37 citations

Ibogaine is a plant-derived alkaloid and dissociative psychedelic that demonstrates anti-addictive properties with several substances of abuse, including alcohol. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic known to occasion potent mystical-type experiences and also demonstrates anti-addictive properties. The potential therapeutic effects of both compounds...

DOI: 10.1016/bs.pbr.2018.08.002 Full text 5-MEO-DMT Alcohol use disorder Ibogaine Combination psychedelic therapy +16

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Progress in Brain Research 2018 John Martin Corkery 62 citations

Ibogaine is an indole alkaloid found in the root bark of the Iboga shrub native to west Africa possessing hallucinogenic properties. For centuries it has been used in religious ceremonies and to gain spiritual enlightenment. However, since the early 1960s, its apparent ability to reduce craving for psychoactive substances including alcohol, cocaine, methamphetamine, opiates, and nicotine has...

DOI: 10.1016/bs.pbr.2018.08.005 Full text Cure/remedy Deaths/fatalities Opiate/opioid addiction UK +6